Follow
Olasunkanmi Joshua Olaoye
Olasunkanmi Joshua Olaoye
Lecturer of Computer Science
Verified email at calebuniversity.edu.ng
Title
Cited by
Cited by
Year
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia
JM Gawel, AE Shouksmith, YS Raouf, N Nawar, K Toutah, S Bukhari, ...
European Journal of Medicinal Chemistry 201, 112411, 2020
362020
Characterization of conformationally constrained benzanilide scaffolds for potent and selective HDAC8 targeting
MM Hassan, J Israelian, N Nawar, G Ganda, P Manaswiyoungkul, ...
Journal of Medicinal Chemistry 63 (15), 8634-8648, 2020
322020
Recent advances in chemical biology using benzophenones and diazirines as radical precursors
MM Hassan, OO Olaoye
Molecules 25 (10), 2285, 2020
292020
Development of HDAC inhibitors exhibiting therapeutic potential in T-cell prolymphocytic leukemia
K Toutah, N Nawar, S Timonen, H Sorger, YS Raouf, S Bukhari, J von Jan, ...
Journal of medicinal chemistry 64 (12), 8486-8509, 2021
282021
Class I/IIb-selective HDAC inhibitor exhibits oral bioavailability and therapeutic efficacy in acute myeloid leukemia
AE Shouksmith, JM Gawel, N Nawar, D Sina, YS Raouf, S Bukhari, L He, ...
ACS Medicinal Chemistry Letters 11 (1), 56-64, 2019
242019
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma
N Nawar, S Bukhari, AA Adile, Y Suk, P Manaswiyoungkul, K Toutah, ...
Journal of medicinal chemistry 65 (4), 3193-3217, 2022
182022
Unique molecular interaction with the histone deacetylase 6 catalytic tunnel: Crystallographic and biological characterization of a model chemotype
OO Olaoye, PR Watson, N Nawar, M Geletu, A Sedighi, S Bukhari, ...
Journal of medicinal chemistry 64 (5), 2691-2704, 2021
182021
Optimization of a high-throughput fluorescence polarization assay for STAT5B DNA binding domain-targeting inhibitors
P Manaswiyoungkul, F Erdogan, OO Olaoye, AD Cabral, ED de Araujo, ...
Journal of Pharmaceutical and Biomedical Analysis 184, 113182, 2020
72020
Halogenated phenylsulfonamide hydroxamic acid compounds, compositions and uses thereof as selective hdac6 inhibitors
PT Gunning, O Olaoye, K Toutah, AE Shouksmith, JM Shouksmith, ...
US Patent App. 17/593,877, 2022
2022
Novel Molecular Templates Targeting Histone Deacetylase 6: Promising Strategy Towards Clinical Translation
OO Olaoye
University of Toronto (Canada), 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–10